Article Details

Ravulizumab in myasthenia gravis | NDT - Dove Medical Press

Retrieved on: 2023-12-01 23:42:17

Tags for this article:

Click the tags to see associated articles and topics

Ravulizumab in myasthenia gravis | NDT - Dove Medical Press. View article details on hiswai:

Excerpt

... monoclonal antibody eculizumab to have an extended half-life and duration of action. ... antibody-negative gMG patients with anti-MuSK antibodies.

Article found on: www.dovepress.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo